X0609 4 2026-05-15 0000313143 HAEMONETICS CORP HAE 0001950021 Galvin Roy false 125 SUMMER STREET BOSTON MA 02110 1 EVP, Chief Commercial Officer 0 Common Stock 2026-05-15 4 F 0 879 56.29 D 12347 D Common Stock 2026-05-15 4 A 0 27535 A 39882 D Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I. This number includes unvested RSUs previously reported as well as 415 shares acquired by the reporting person under the Haemonetics Corporation 2007 Employee Stock Purchase Plan (as amended and/or restated from time to time) on April 30, 2026. The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three annual installments with forty percent of the total award vesting on the first anniversary of the date of grant, forty percent vesting on the second anniversary of the date of grant and the remaining twenty percent vesting on the third anniversary of the date of grant. Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. /s/ Thomas V. Powers, attorney-in-fact for Mr. Galvin 2026-05-19